Newly Discovered Dinosaur Is T. Rex's Awkward Cousin
Scientists have discovered a new species of tyrannosauroid—the group of dinosaurs that includes Tyrannosaurus rex. The finding offers new insights into how massive predators like T. rex evolved, transforming the tyrannosauroid tree of life, according to a study published today.
In the early 1970s, researchers unearthed two partial tyrannosauroid skeletons in the Bayanshiree Formation, a geological formation in Mongolia. Researchers originally believed the fossils were from a previously discovered tyrannosauroid species from China, Alectrosaurus olseni.
Paleontologists hailed the discovery of A. olseni as significant and said a comparative phylogenetic analysis was long overdue, the authors wrote in the study.
Recently, an international team of researchers led by paleontologists Jared Voris and Darla Zelenitsky from the University of Calgary finally reexamined the fossils. After comparing the morphology of the tyrannosauroid remains to similar species, they assigned the fossils to a new genus and species: Khankhuuluu mongoliensis. Their findings are published in Nature.
Khankhuuluu was a medium-sized predator—roughly the size of a grizzly bear—with a skull up to 27 inches long (70 centimeters) and a femur measuring nearly 26 inches (67 cm).
The iconic T. rex was just one member of a group of fearsome predatory dinosaurs known as Eutyrannosaurians. These dinosaurs—characterized by their enormous size, powerful jaws, short arms, and long legs—dominated the landscape around 66 million years ago.
However, how these massive creatures evolved from their smaller, ganglier ancestors remains unclear. This gap exists because of a scarcity of fossils from 'mid-grade' tyrannosauroids, species that represent an evolutionary middle ground between the group's earliest, smallest members and the colossal T. rex. According to the study, Khankhuuluu mongoliensis fits this middle ground in terms of size and shares features with both the massive Tyrannosaurini and the small, shallow-snouted Alioramini clades that came later.
In the tyrannosauroid evolutionary tree, K. mongoliensis is positioned just outside of the Eutyrannosaurians, having branched off about 90 million years ago during the Late Cretaceous period, the study suggests. The specimen is described as one of the 'best-represented mid-grade tyrannosauroids' and serves as an 'exemplar ancestral form for the clade,' the authors wrote. Importantly, Khankhuuluu has features that characterize juvenile eutyrannosaurians, but not adults, including a slender build and longer forearms than legs.
These findings highlight the importance of heterochrony—changes in the timing of developmental processes, such as delaying skull development—in tyrannosauroid evolution, indicating that Eutyrannosaurians went through a period of accelerated or prolonged growth as they matured.
Based on the geographic distribution and morphological similarities between Khankhuuluu and other tyrannosauroids, the study proposes that mid-sized dinosaurs like Khankhuuluu initially spread from Asia to North America. There, they evolved into several types of Eutyrannosaurians, including T. rex, that remained in North America as they diversified in both form and ecological role. Later, tyrannosauroids migrated back to Asia, giving rise to the Alioramini and Tyrannosaurini clades.
In yet another dispersal, Tyrannosaurini dispersed back to North America, where they evolved into the gigantic Tyrannosaurus species we know and love. They dominated as apex predators for 2 million years, until the end-Cretaceous mass extinction.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
These may be the 3 most effective non-drug ways to treat knee arthritis
A knee brace appears to be one of the more effective ways to treat the pain - as well as improve function and stiffness - from osteoarthritis, the common degenerative process where the cartilage cushioning the joint deteriorates over time. Researchers in China ranked the relative effectiveness of a dozen treatments, ranging from laser and ultrasound therapy to wedged insoles and kinesiology tape, studied in 139 randomized controlled trials. Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Based on the results from 9,644 participants, the simple knee brace ranked highest in effectiveness to alleviate symptoms of arthritis, the researchers concluded. However, 'the challenge,' said Prakash Jayabalan, the director of musculoskeletal research at the Shirley Ryan AbilityLab in Chicago, 'is getting patients to actually wear knee braces.' Jayabalan and other clinicians who weren't involved in the study said knee braces can provide certain people immediate relief by supporting the load on the joint. But, some patients find braces uncomfortable to wear. Hydrotherapy and exercises such as weightlifting and yoga placed second and third in the meta-analysis ranking. Hydrotherapy, also known as water exercises or aquatherapy, is a treatment approach designed to improve symptoms. And experts said staying active and maintaining a healthy weight are the most effective ways to relieve symptoms of knee osteoarthritis. 'Both of those can improve symptoms and slow the progression of arthritis,' said Morgan Jones, a sports medicine orthopedic surgeon at Mass General Brigham. The peer-reviewed study published in PLOS One on Wednesday. It was led by Yuan Luo, a researcher in the department of rehabilitation at the First People's Hospital of Neijiang, China, who did not respond to questions by the time of publication. - - - What causes knee osteoarthritis? When cartilage in the knee breaks down, the joint is left with 'bone on bone motion,' Jayabalan said. Cartilage can't repair itself like other tissues in the body and, oftentimes, people don't know they've lost the cartilage in their knee until it's gone, he said. There are two common risk factors for knee arthritis - a previous knee injury such as an ACL tear and unhealthy weight gain, said Steve Messier, the director of the J.B. Snow Biomechanics Laboratory at Wake Forest University. Every pound of additional body weight amounts to four pounds of stress on the knees when a person is walking, Messier said. Once someone has arthritis in their knee, they need to make broad lifestyle changes with regular exercise to manage the pain, he said. 'It really doesn't matter what type of exercise you do, just so you're being active,' Messier said. 'They all will reduce pain.' Other clinicians agree staying active is one of the best ways to relieve knee arthritis pain. It's the first recommendation in guidelines published in 2019 from the Osteoarthritis Research Society International. Around 33 million U.S. adults have osteoarthritis, according to the Centers for Disease Control and Prevention. People commonly take NSAIDs such as ibuprofen to relieve the symptoms. But, these pain-relievers can damage the lining of your gut. Jayabalan said he recommends people use NSAIDs for no more than 10 days when they're experiencing 'debilitating pain' that is impacting their function. 'You should not be taking these every day,' he said. Knee replacements have long been the gold standard for damaged joints, but it can take up to a year for some people to fully recover from surgery. Emerging alternatives target the nerves to stop the knee pain and block blood flow to reduce inflammation. 'Two people can have the same amount of structural damage in their knee and have totally different pain profiles,' said Jones, also an assistant professor of orthopedic surgery at Harvard Medical School. 'The decision for knee replacement ends up being really individualized, and the focus is on the person's symptoms.' - - - What did the study find? The knee brace ranked best on various scores of pain, stiffness and function, and had the 'highest probability of being the best technique,' the researchers wrote. Jones said a knee brace can be 'very effective' in people who have arthritis in certain compartments of the knee because the brace can shift the load to another part of the joint. 'But, if somebody has arthritis throughout their knee, an unloader brace is not as likely to be helpful,' he said. 'They don't have a more-normal area to off-load the force to.' The researchers compared a dozen interventions: low-level laser therapy, high-intensity laser therapy, transcutaneous electrical nerve stimulation, interferential current, short wave diathermy, ultrasound, lateral wedged insole, knee brace, exercise, hydrotherapy, kinesio taping and extracorporeal shock wave therapy. Hydrotherapy ranked second in some scores. Water buoyancy takes pressure off the knee joints and helps improve range of motion for some people, Jayabalan said. Ultrasound pulse therapy to treat knee arthritis 'remains contentious' and performed the worst across multiple scores, the researchers wrote. And, they concluded that wedged insoles, which attempt to shift the load on the knee by lifting one side of the foot, did not 'outperform neutral devices in pain reduction.' Insoles used to be a popular therapy for knee osteoarthritis but 'multiple studies' have shown they don't help, Jones said. - - - The study's limitations Many of the studies in the meta-analysis are short, six to 12 weeks, Messier said. Therefore, the results support only short-term pain relief from these treatments. 'It may relieve pain for a little while, but it's not going to change pain in the long run,' Messier said. 'The most effective thing they have here is exercise.' Jayabalan said none of the studies are looking at whether the treatments led to mechanistic improvements in the knee - 'they were not regrowing cartilage, or something like that.' Instead, the studies recorded clinical observations that these treatments may provide a potential benefit. And, many of the randomized controlled trials were conducted on small groups of participants, Jones said. 'There's a lot of variability in the studies and how long they follow their patients,' he said. Related Content 3-pound puppy left in trash is rescued, now thriving How to meet street cats around the world 'Jaws' made people fear sharks. 50 years later, can it help save them?
Yahoo
an hour ago
- Yahoo
Skull Discovered in 1933 Sheds Light on Ancient Human Species
Two new studies published in Science and Cell have shed light on a mysterious skull found in China, and in the process have provided insight into the lives of a previously little-known ancient human. The 'Dragon Man' skull was found in Harbin City, China, during an excavation in 1933. The skull, which was terrifically well-preserved, was kept by the discovering archaeologist because he feared authorities would confiscate the skull. In 2018, shortly before he died, the archaeologist donated the skull for analysis. The Dragon Man's skull was much larger than modern humans, bearing an expanded brain volume as well as deep, prominent eyebrow ridges, a flat face, a wide nose, and no chin. Scientists estimated that the person lived roughly 146,000 years ago. After studying molecules from a molar in the skull, Qiaomei Fu, a geneticist at Beijing's Institute of Vertebrate Paleontology and Paleoanthropology, determined that it likely belonged to a Denisovan. Denisovans have long been a mystery to scientists, as they only had the pinkie bone of an adolescent, which was discovered in 2010 and rumor genes fitfully present in modern humans available to study. Though DNA has long shown that Denisovans were interbred with Neandertals and modern humans, with as much as five percent of their genetic composition existing in people from Melanesia and other Southeast Asian regions, this is the first Denisovan skull which has been discovered. 'After 15 years, we give the Denisovan a face,' Fu told National Geographic. 'It's really a special feeling, I feel really happy.' In their study published in Cell, the researchers added: "This is the first detailed morphological blueprint for Denisovan populations.' The discovery redefines the history of human evolution in South Asia, with researchers now able to investigate how the Denisovans' contributions to ancient culture still reverberate in the modern day. "Having a well-preserved skull like this one allows us to compare the Denisovans to many more different specimens found in very different places,' Bence Viola, an archaeologist not involved with the study, told New Scientist. 'We can finally think about their adaptations to climate, mobility, and even social behavior.' Skull Discovered in 1933 Sheds Light on Ancient Human Species first appeared on Men's Journal on Jun 20, 2025
Yahoo
4 hours ago
- Yahoo
Biotech industry faces off: US vs. China
China has become a significant player in the biotech space, potentially threatening the lead the US holds. EY Americas industry markets leader for health sciences and wellness Arda Ural sits down with Josh Lipton and Yahoo Finance Senior Reporter Anjalee Khemlani to discuss the dynamics between the US and China in the biotech industry. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here According to a recent report from the Harvard Belfer Center for Science and International Affairs, China has the most immediate opportunity to overtake the United States in biotechnology. For more, let's welcome in Arta Rawi America's industry markets leader and Health Sciences and wellness, as well as Yahoo Finance's very own Anjali Camlani. Welcome to you both. All right, I'll start with you. Uh, maybe it's just a big question, big picture question. Does the US have the investment power, in your opinion, to overtake China in biotech? Yeah, thanks for having me. Uh, the biotech is the innovation feeder to the big pharmaceuticals and it only uh nurtures well in an ecosystem. So to answer your question, what do you need in that ecosystem for that to nurture? Uh, investment capacity, which we have been having for the last, you know, decades, if you will, to kind of keep investing in that innovation to move on. NIH has been probably the world's largest VC over $40 billion in non-dilute funding into the entrepreneurial startups. Then you have talent who has been, you know, coming all these top universities and MDs and PhDs who are dedicated to advance it. And then you need this technology transfer system so that those intellectual property translate into a startup. And then with that investment capacity, it keeps growing and then through testing and going to the humans and then ultimately being developed for everyone's use. So, uh, yes, the US still has the capacity to invest, but it is not potentially the only game in town given the development coming from China. I'm curious, Arta, because we know, I know you've been tracking the deals and uh, we've seen the number of deals steadily increasing over the years. I saw, uh, one of the ones that you sent, which looks at the number of deals so far to date for 2025 is more than half of what we saw in 2024. So we can expect that to really outpace 2024. What does that mean though? Because I know that some of the deals that are happening are more, um, what you would call licensing deals, right? It's not necessarily that this money is going to from scratch investment and innovation, but it's more stuff that has already happened and is built up. Talk to me about that and why that matters. I mean, first of all, the numbers are pretty compelling. A couple years ago, we had pretty much like no deals under a billion dollars in 2016. And as of last year, there were $30 billion worth of licensing deals from Chinese assets into the US, and 2025 is a very strong start, so they're definitely going to beat that number. So the reason why this is happening is in 2015, Chinese Communist Party put a priority of investing in biotech and that was a priority sectors. And it was 10 years ago, and that 10 years of journey started to play out for their benefit because China historically has been known for this active product ingredients and excipients, which is like the chemicals that pharmaceuticals were using to make small molecule products. And that journey now is taking them to upstream to more advanced innovation. Probably we still have not seen a first in class, but clearly they are going for best in class, like those are the shots on goal if you are seeing more and more. Well, that's why, that would be my question because I know that we've seen sort of they're doing copycats or metoos in terms of the type of innovation coming out of China. Um, do we expect that they have the wherewithal to outdo the US then in that sense, in terms of coming up with the next blockbuster for the entire world? I mean, there are a couple examples, early examples that some of the Chinese based assets actually head-to-head comparisons, you know, beat or exceed, at least match the efficacy and safety profile of some of the Western developed compounds. But this is also a journey as the audio question. So what is it, what do they need more to get there? So they have the talent. I mean a lot of Western educated MDs and PhDs went back to China working on that. The government itself as a part of prioritization program have been investing in it. So then the question is, do they have an exit strategy for those entrepreneurs? And that I think is where they are lacking because there's no like an IPO market that is comparable to the Western standards. There's no like an M&A exit until recently. I think that's where the weakness kind of may be the opportunity for them to come up. But the deals we were talking about, they're because of the intellectual property concerns, because of the concerns of reliability and trust in the data because, you know, there's no such institution in the world like FDA that everyone trusts and hopefully continue to trust. And for that reason, the deals seem to be more asset purchases. So I'm not taking a risk by operating in China, but I'm buying the asset and in a licensing deal, and I'll continue to develop it, especially if you can make this cheaper and faster in China, which has been their competitive advantage over the Western companies, then you bring that into a human fast and then the human testing can be done, validations can be done in the more Western setting. I think that can be a winning formula for the industry. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
